First Time Loading...

Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 195.95 EUR 1.01% Market Closed
Updated: May 23, 2024

Intrinsic Value

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. [ Read More ]

The intrinsic value of one DIM stock under the Base Case scenario is 196.64 EUR. Compared to the current market price of 195.95 EUR, Sartorius Stedim Biotech SA is Fairly Valued.

Key Points:
DIM Intrinsic Value
Base Case
196.64 EUR
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sartorius Stedim Biotech SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DIM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Sartorius Stedim Biotech SA

Provide an overview of the primary business activities
of Sartorius Stedim Biotech SA.

What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?

What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?

Summarize the latest earnings call
of Sartorius Stedim Biotech SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sartorius Stedim Biotech SA.

Provide P/S
for Sartorius Stedim Biotech SA.

Provide P/E
for Sartorius Stedim Biotech SA.

Provide P/OCF
for Sartorius Stedim Biotech SA.

Provide P/FCFE
for Sartorius Stedim Biotech SA.

Provide P/B
for Sartorius Stedim Biotech SA.

Provide EV/S
for Sartorius Stedim Biotech SA.

Provide EV/GP
for Sartorius Stedim Biotech SA.

Provide EV/EBITDA
for Sartorius Stedim Biotech SA.

Provide EV/EBIT
for Sartorius Stedim Biotech SA.

Provide EV/OCF
for Sartorius Stedim Biotech SA.

Provide EV/FCFF
for Sartorius Stedim Biotech SA.

Provide EV/IC
for Sartorius Stedim Biotech SA.

Show me price targets
for Sartorius Stedim Biotech SA made by professional analysts.

What are the Revenue projections
for Sartorius Stedim Biotech SA?

How accurate were the past Revenue estimates
for Sartorius Stedim Biotech SA?

What are the Net Income projections
for Sartorius Stedim Biotech SA?

How accurate were the past Net Income estimates
for Sartorius Stedim Biotech SA?

What are the EPS projections
for Sartorius Stedim Biotech SA?

How accurate were the past EPS estimates
for Sartorius Stedim Biotech SA?

What are the EBIT projections
for Sartorius Stedim Biotech SA?

How accurate were the past EBIT estimates
for Sartorius Stedim Biotech SA?

Compare the revenue forecasts
for Sartorius Stedim Biotech SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sartorius Stedim Biotech SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sartorius Stedim Biotech SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sartorius Stedim Biotech SA compared to its peers.

Compare the P/E ratios
of Sartorius Stedim Biotech SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Sartorius Stedim Biotech SA with its peers.

Analyze the financial leverage
of Sartorius Stedim Biotech SA compared to its main competitors.

Show all profitability ratios
for Sartorius Stedim Biotech SA.

Provide ROE
for Sartorius Stedim Biotech SA.

Provide ROA
for Sartorius Stedim Biotech SA.

Provide ROIC
for Sartorius Stedim Biotech SA.

Provide ROCE
for Sartorius Stedim Biotech SA.

Provide Gross Margin
for Sartorius Stedim Biotech SA.

Provide Operating Margin
for Sartorius Stedim Biotech SA.

Provide Net Margin
for Sartorius Stedim Biotech SA.

Provide FCF Margin
for Sartorius Stedim Biotech SA.

Show all solvency ratios
for Sartorius Stedim Biotech SA.

Provide D/E Ratio
for Sartorius Stedim Biotech SA.

Provide D/A Ratio
for Sartorius Stedim Biotech SA.

Provide Interest Coverage Ratio
for Sartorius Stedim Biotech SA.

Provide Altman Z-Score Ratio
for Sartorius Stedim Biotech SA.

Provide Quick Ratio
for Sartorius Stedim Biotech SA.

Provide Current Ratio
for Sartorius Stedim Biotech SA.

Provide Cash Ratio
for Sartorius Stedim Biotech SA.

What is the historical Revenue growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the historical Net Income growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the current Free Cash Flow
of Sartorius Stedim Biotech SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sartorius Stedim Biotech SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sartorius Stedim Biotech SA

Current Assets 2.1B
Cash & Short-Term Investments 727.7m
Receivables 401.4m
Other Current Assets 948.5m
Non-Current Assets 6.4B
Long-Term Investments 41m
PP&E 1.7B
Intangibles 4.6B
Other Non-Current Assets 64.5m
Current Liabilities 975.4m
Accounts Payable 402.8m
Accrued Liabilities 68.1m
Other Current Liabilities 504.5m
Non-Current Liabilities 3.6B
Long-Term Debt 3.1B
Other Non-Current Liabilities 553.6m
Efficiency

Earnings Waterfall
Sartorius Stedim Biotech SA

Revenue
2.7B EUR
Cost of Revenue
-1.5B EUR
Gross Profit
1.2B EUR
Operating Expenses
-762.5m EUR
Operating Income
404.9m EUR
Other Expenses
-150.2m EUR
Net Income
254.7m EUR

Free Cash Flow Analysis
Sartorius Stedim Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DIM Profitability Score
Profitability Due Diligence

Sartorius Stedim Biotech SA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROIC
58/100
Profitability
Score

Sartorius Stedim Biotech SA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

DIM Solvency Score
Solvency Due Diligence

Sartorius Stedim Biotech SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
50/100
Solvency
Score

Sartorius Stedim Biotech SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DIM Price Targets Summary
Sartorius Stedim Biotech SA

Wall Street analysts forecast DIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIM is 261.94 EUR with a low forecast of 202 EUR and a high forecast of 378 EUR.

Lowest
Price Target
202 EUR
3% Upside
Average
Price Target
261.94 EUR
34% Upside
Highest
Price Target
378 EUR
93% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Sartorius Stedim Biotech SA

Shareholder Return

DIM Price
Sartorius Stedim Biotech SA

1M 1M
-6%
6M 6M
-4%
1Y 1Y
-21%
3Y 3Y
-44%
5Y 5Y
+57%
10Y 10Y
+841%
Annual Price Range
195.95
52w Low
162
52w High
284.5
Price Metrics
Average Annual Return 35.41%
Standard Deviation of Annual Returns 59.94%
Max Drawdown -70%
Shares Statistics
Market Capitalization 18.1B EUR
Shares Outstanding 97 315 209
Percentage of Shares Shorted
N/A

DIM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA

Country

France

Industry

Life Sciences Tools & Services

Market Cap

18.1B EUR

Dividend Yield

0.35%

Description

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,409 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Contact

PACA
Aubagne
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
+33442845600.0
https://www.sartorius.com/en/company/about-sartorius-stedim-biotech-sa

IPO

1994-10-20

Employees

10 409

Officers

CEO & DIrector
Dr. Rene Faber
CFO & Member of Executive Board
Mr. Rainer Lehmann
Head of Investor Relations
Ms. Petra Muller
Head of Corporate Communications & IR
Ms. Petra Kirchhoff
Head of Controlling BPS
Olivier Guitard

See Also

Discover More
What is the Intrinsic Value of one DIM stock?

The intrinsic value of one DIM stock under the Base Case scenario is 196.64 EUR.

Is DIM stock undervalued or overvalued?

Compared to the current market price of 195.95 EUR, Sartorius Stedim Biotech SA is Fairly Valued.